selected scholarly activity
-
chapters
-
conferences
- PATIENT SELECTION, REGION AND TREATING PHYSICIAN ARE RELATED TO ESTIMATES OF ORAL ANTICOAGULATION USE IN ATRIAL FIBRILLATION: A SYSTEMATIC REVIEW AND META-ANALYSIS. Journal of the American College of Cardiology. 325-325. 2020
- When are atrial fibrillation patients at risk to discontinue anticoagulation treatment? Results from the GLORIA-AF Registry. European Heart Journal. 1007-1007. 2018
- Epidemiological Trends in Atrial Fibrillation in Europe: The EURObservational Research Programme in Atrial Fibrillation Pilot and Long-Term Registries and Euro Heart Survey on Atrial Fibrillation. Circulation. 2017
- Scope and Consistency of Adherence Related Outcomes in Randomized Controlled Trials of Interventions for Improving Medication Adherence. Arthritis & Rheumatology. 2017
- Changes in thromboembolic risk profile and antithrombotic therapy use over a decade: a comparison of Euro Heart Survey on AF and EURObservational research programme AF pilot registry. European Heart Journal. 1220-1221. 2017
- PERSISTENCE WITH THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION: THE GLORIA-AF REGISTRY. Journal of the American College of Cardiology. 374-374. 2017
- Progression to asymptomatic atrial fibrillation as a prognostic index: the Euro Heart Study. European Heart Journal. 525-525. 2015
- Management of dyspepsia symptoms on dabigatran during RELY-ABLE: a long-term follow up of RE-LY patients.. Pharmacotherapy. E185-E186. 2014
- Echocardiographic Assessment of Tricuspid Valve Regurgitation Induced by Temporary or Permanent Leads in Patients Undergoing Ablation or Permanent Device Implantation. Canadian Journal of Cardiology. S160-S160. 2013
- Management of dyspepsia symptoms on dabigatran during RELY-ABLE: long-term follow up study after RE-LY. European Heart Journal. 102-102. 2013
- Cluster Randomized Controlled Trial to Test The Effect of a Multifaceted Comprehensive Cardiovascular Care Intervention on Clinical Outcomes in Atrial Fibrillation Patients Receiving Dabigatran. Circulation. 2012
- 902 Cluster Randomized Controlled Trial to Test the Effect of Computer-Generated Individualized Audit and Feedback to Patients and Physicians on Clinical Outcomes in Atrial Fibrillation Patients Participating in a Large Multi-Center Trial of Dabigatran. Canadian Journal of Cardiology. S417-S417. 2012
- Net clinical benefit of apixaban among patients with atrial fibrillation. European Heart Journal. 58-58. 2012
- Effect of dronedarone in patients with permanent atrial fibrillation during the ATHENA study. European Heart Journal. 618-618. 2011
- Importance of algorithm-based warfarin dosing in the quality of anticoagulation control in atrial fibrillation - a multilevel analysis. European Heart Journal. 461-461. 2011
- Randomized comparison of the DAWN AC computer program and a simple manual nomogram for quality of warfarin dosing. Journal of Thrombosis and Haemostasis. 302-302. 2011
- Vitamin K antagonist dosing methods and individual patient quality of INR control in the international active W anticoagulation study. Journal of Thrombosis and Haemostasis. 445-446. 2011
- Systematic Review to Identify Validated Manual Warfarin Maintenance Dosing Tools. Blood. 1554-1554. 2010
- A novel user-friendly score to assess one-year risk of major bleeding in atrial fibrillation patients: the Euro HeartSurvey. European Heart Journal. 923-923. 2010
- Impact of the Modified Henry Ford Warfarin Maintenance Dosing Algorithm an Quality of Anticoagulation at a Specialist Anticoagulation Clinic. Circulation. S1150-S1150. 2009
- A simple, new risk factor based approach to refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation: The Euro Heart Survey on atrial fibrillation. European Heart Journal. 979-979. 2009
- Euro heart survey on AF: costs of Atrial Fibrillation (AF) for ATHENA-like patients in Greece, Italy, Poland, Spain and the Netherlands. European Heart Journal. 240-240. 2009
- Female gender and vascular disease are true risk factors for stroke in patients with atrial fibrillation: data from the Euro Heart Survey. European Heart Journal. 86-86. 2009
- Progression from paroxysmal atrial fibrillation to more sustained forms: clinical correlates and therapeutical consequences. European Heart Journal. 84-85. 2009
- Validation of contemporary risk stratification schema for predicting stroke and thromboembolism in real world atrial fibrillation patients from the Euro Heart Survey on Atrial Fibrillation. European Heart Journal. 598-598. 2009
- Underuse of Evidence Based Methods for Management of Warfarin in Atrial Fibrillation Patients in Hamilton, Canada. Journal of the American College of Cardiology. A368-A368. 2009
- Improved anti-thrombotic therapy in a guidelines-based, nurse-driven, ICT-supported disease management program for patients in atrial fibrillation. Acta Cardiologica. 145-145. 2009
- PCV93 FACTORS DETERMINING UTILITY MEASURED WITHTHE EQ-5D IN PATIENTS WITH A TRIAL FIBRILLATION. Value in Health. A410-A410. 2008
- Autonomic trigger patterns and anti-arrhythmic treatment of atrial fibrillation: data from the Euro Heart Survey. European Heart Journal. 537-537. 2007
- 856 The impact of heart failure on the characteristics and management of atrial fibrillation patients. European Journal of Heart Failure, Supplement. 186-186. 2007
- Guideline adherent antithrombotic treatment is associated with improved cardiovascular outcome compared to undertreatment in real-life atrial fibrillation patients at high risk for stroke. Circulation. 834-834. 2006
- Should we abandon the paradigm of withholding oral anticoagulation in paroxysmal atrial fibrillation?. Circulation. 834-834. 2006
- Antithrombotic drug prescription and its rationale among general practitioners, internal medicine specialists and cardiologists in The Netherlands. The EXAMINE-AF study. European Heart Journal. 834-834. 2006
- Guideline adherent antithrombotic treatment is associated with improved outcome compared to undertreatment in real life atrial fibrillation patients. European Heart Journal. 446-447. 2006
- The cost of atrial fibrillation management in Europe: a cross-sectional study on resource use during admissions and outpatient clinic visits in the Euro Heart Survey cohort. European Heart Journal. 579-579. 2006
- The oldest old patients have a lower chance for receiving guidelines recommended atrial fibrillation therapy. The experience of the Euro Heart Survey on atrial fibrillation. Journal of the American College of Cardiology. 253A-254A. 2006
- Patients with atrial fibrillation induced tachycardiomyopathy are at high risk for stroke. Circulation. U521-U521. 2005
- Vagal and adrenergic atrial fibrillation is found frequently among patients in the Euro Heart Survey. European Heart Journal. 593-593. 2005
- Which factors determine oral anticoagulation prescription in real life atrial fibrillation patients?. European Heart Journal. 733-733. 2005
- Women with atrial fibrillation are less aggressively treated than men. European Heart Journal. 736-736. 2005
- 2055 Which factors determine the application of reperfusion therapy in ST-elevation acute coronary syndromes? Lessons from the Euro-Heart acute coronary syndromes survey. European Heart Journal. 379-379. 2003
-
journal articles
- ASH living guidelines on use of anticoagulation for thromboprophylaxis in patients with COVID-19: executive summary.. Blood Advances. bloodadvances.2024014219. 2024
- GRADE Guidance 39: Using GRADE-ADOLOPMENT to adopt, adapt or create contextualized recommendations from source guidelines and evidence syntheses. Journal of Clinical Epidemiology. 174:111494-111494. 2024
- Core outcome set developers should consider and specify the level of granularity of outcome domains. Journal of Clinical Epidemiology. 169:111307-111307. 2024
- Representation of published core outcome sets in practice guidelines. Journal of Clinical Epidemiology. 169:111311-111311. 2024
- The INGUIDE International Guideline Training and Certification Programme. Clinical and Public Health Guidelines. 1. 2024
- American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing. Blood Advances. 7:7101-7138. 2023
- Antibiotic prescribing guideline recommendations in COVID-19: a systematic survey. EClinicalMedicine. 65:102257-102257. 2023
- Proposed triggers for retiring a living systematic review. BMJ Evidence-Based Medicine. 28:348-352. 2023
- Prospective collaborative recommendation development: a novel model for more timely and trustworthy guidelines. Journal of Clinical Epidemiology. 162:156-159. 2023
- Good or best practice statements: proposal for the operationalisation and implementation of GRADE guidance. BMJ Evidence-Based Medicine. 28:189-196. 2023
- Cuker A, Tseng EK, Nieuwlaat R, et al. American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients. Blood Adv. 2021;5(20):3951-3959.. Blood Advances. 7:811. 2023
- Which actionable statements qualify as good practice statements In Covid-19 guidelines? A systematic appraisal. BMJ Evidence-Based Medicine. 27:361-369. 2022
- GRADE guidance 35: update on rating imprecision for assessing contextualized certainty of evidence and making decisions. Journal of Clinical Epidemiology. 150:225-242. 2022
- American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis for patients with COVID-19: March 2022 update on the use of anticoagulation in critically ill patients. Blood Advances. 6:4975-4982. 2022
- American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of therapeutic-intensity anticoagulation in acutely ill patients. Blood Advances. 6:4915-4923. 2022
- A Framework for the Development of Living Practice Guidelines in Health Care. ACP journal club. 175:1154-1160. 2022
- An evaluation of the COVID-19 recommendation map identified diverging clinical and public health guidance. Journal of Clinical Epidemiology. 147:83-94. 2022
- Standardized wording to improve efficiency and clarity of GRADE EtD frameworks in health guidelines. Journal of Clinical Epidemiology. 146:106-122. 2022
- In-Hospital Macro-, Meso-, and Micro-Drivers and Interventions for Antibiotic Use and Resistance: A Rapid Evidence Synthesis of Data from Canada and Other OECD Countries. Canadian Journal of Infectious Diseases and Medical Microbiology. 2022:1-11. 2022
- New methods facilitated the process of prioritizing questions and health outcomes in guideline development. Journal of Clinical Epidemiology. 143:91-104. 2022
- American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on postdischarge thromboprophylaxis. Blood Advances. 6:664-671. 2022
- Cost-effectiveness of diagnostic strategies for venous thromboembolism: a systematic review. Blood Advances. 6:544-567. 2022
- A taxonomy and framework for identifying and developing actionable statements in guidelines suggests avoiding informal recommendations. Journal of Clinical Epidemiology. 141:161-171. 2022
- A modeling approach to derive baseline risk estimates for GRADE recommendations: Concepts, development, and results of its application to the American Society of Hematology 2019 guidelines on prevention of venous thromboembolism in surgical hospitalized patients. Journal of Clinical Epidemiology. 140:69-78. 2021
- How to write a guideline: a proposal for a manuscript template that supports the creation of trustworthy guidelines. Blood Advances. 5:4721-4726. 2021
- American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients. Blood Advances. 5:3951-3959. 2021
- Development and application of health outcome descriptors facilitated decision-making in the production of practice guidelines. Journal of Clinical Epidemiology. 138:115-127. 2021
- Clinical practice guideline for transcatheter versus surgical valve replacement in patients with severe aortic stenosis in Latin America. Heart. 107:1450-1457. 2021
- GRADE notes: How to use GRADE when there is “no” evidence? A case study of the expert evidence approach. Journal of Clinical Epidemiology. 137:231-235. 2021
- Canadian Rheumatology Association Recommendation for the Use of COVID-19 Vaccination for Patients With Autoimmune Rheumatic Diseases. Journal of Rheumatology. 48:1330-1339. 2021
- Systematic review of treatment gaps in oral anticoagulant use in atrial fibrillation. Thrombosis Update. 4:100053-100053. 2021
- Recommendation mapping of the World Health Organization's guidelines on tuberculosis: A new approach to digitizing and presenting recommendations. Journal of Clinical Epidemiology. 134:138-149. 2021
- Methodological considerations for investigating oral anticoagulation persistence in atrial fibrillation. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. 7:251-260. 2021
- Coronavirus Disease 2019 and Antimicrobial Resistance: Parallel and Interacting Health Emergencies. Clinical Infectious Diseases. 72:1657-1659. 2021
- Systematic review and meta-analysis of outcomes in patients with suspected pulmonary embolism. Blood Advances. 5:2237-2244. 2021
-
Methodological assessment of Mexican Clinical Practice Guidelines:
GRADE framework adherence and critical appraisal. Journal of Evaluation in Clinical Practice. 27:385-390. 2021 - The quality of subgroup analyses in chronic pain randomized controlled trials: a methodological review. Korean Journal of Pain. 34:139-155. 2021
- Control of Severe, Life-Threatening External Bleeding in the Out-of-Hospital Setting: A Systematic Review. Prehospital Emergency Care. 25:235-267. 2021
- American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19. Blood Advances. 5:872-888. 2021
- Development and use of health outcome descriptors: a guideline development case study. Health and Quality of Life Outcomes. 18:167. 2020
- Erratum to “Controversy and debate series on core outcome sets. Paper 3:debate on paper 1 from the perspective of GRADE [Grading of Recommendations Assessment, Development and Evaluation]” [Journal of Clinical Epidemiology 125C (2020) 216-221]. Journal of Clinical Epidemiology. 128:162-162. 2020
- Management of heparin-induced thrombocytopenia: systematic reviews and meta-analyses. Blood Advances. 4:5184-5193. 2020
- 2020 International Consensus on First Aid Science With Treatment Recommendations.. Resuscitation. 142:S284-S334. 2020
- American Society of Hematology 2020 Guidelines for Management of Venous Thromboembolism: Treatment of Deep Vein Thrombosis and Pulmonary Embolism. Blood Advances. 4:4693-4738. 2020
- Scope of Outcomes in Trials and Observational Studies of Interventions Targeting Medication Adherence in Rheumatic Conditions: A Systematic Review. Journal of Rheumatology. 47:1565-1574. 2020
- Controversy and Debate Series on Core Outcome Sets: The SOLAR (Standardized Outcomes Linking Across StakeholdeRs) system and hub and spokes model for direct core outcome measures in health care and its relation to GRADE. Journal of Clinical Epidemiology. 125:216-221. 2020
- Ventilation Techniques and Risk for Transmission of Coronavirus Disease, Including COVID-19. ACP journal club. 173:204-216. 2020
- Pharmacologic thromboprophylaxis in adult patients undergoing neurosurgical interventions for preventing venous thromboembolism. Blood Advances. 4:2798-2809. 2020
- Systematic review and meta-analysis of outcomes in patients with suspected deep vein thrombosis. Blood Advances. 4:2779-2788. 2020
- Comparing low-molecular-weight heparin dosing for treatment of venous thromboembolism in patients with obesity (RIETE registry). Blood Advances. 4:2460-2467. 2020
- Diagnosis of deep vein thrombosis of the upper extremity: a systematic review and meta-analysis of test accuracy. Blood Advances. 4:2516-2522. 2020
- Methodology for the American Society of Hematology VTE guidelines: current best practice, innovations, and experiences. Blood Advances. 4:2351-2365. 2020
- A user guide to the American Society of Hematology clinical practice guidelines. Blood Advances. 4:2095-2110. 2020
- DOACs vs LMWHs in hospitalized medical patients: a systematic review and meta-analysis that informed 2018 ASH guidelines. Blood Advances. 4:1512-1517. 2020
- Diagnosis of deep vein thrombosis of the lower extremity: a systematic review and meta-analysis of test accuracy. Blood Advances. 4:1250-1264. 2020
- Thrombolytics for venous thromboembolic events: a systematic review with meta-analysis. Blood Advances. 4:1539-1553. 2020
- Patient values and preferences regarding VTE disease: a systematic review to inform American Society of Hematology guidelines. Blood Advances. 4:953-968. 2020
- Home vs hospital treatment of low-risk venous thromboembolism: a systematic review and meta-analysis. Blood Advances. 4:500-513. 2020
- Dabigatran Persistence and Outcomes Following Discontinuation in Atrial Fibrillation Patients from the GLORIA-AF Registry. American Journal of Cardiology. 125:383-391. 2020
- The eCOVID-19 living recommendations map and gateway to contextualisation. Cochrane Database of Systematic Reviews. 54-57. 2020
- A meta-epidemiological study of subgroup analyses in cochrane systematic reviews of atrial fibrillation. Systematic Reviews. 8:241. 2019
- Ethical issues in competing clinical trials. Contemporary Clinical Trials Communications. 14:100352-100352. 2019
- Structured decision-making drives guidelines panels' recommendations “for” but not “against” health interventions. Journal of Clinical Epidemiology. 110:23-33. 2019
- A systematic review and meta-analysis of supplemental education in patients treated with oral anticoagulation. Blood Advances. 3:1638-1646. 2019
- The Canadian Community Utilization of Stroke Prevention Study in Atrial Fibrillation in the Emergency Department (C-CUSP ED). Annals of Emergency Medicine. 73:382-392. 2019
- Vitamin K for reversal of excessive vitamin K antagonist anticoagulation: a systematic review and meta-analysis. Blood Advances. 3:789-796. 2019
- Management of direct factor Xa inhibitor–related major bleeding with prothrombin complex concentrate: a meta-analysis. Blood Advances. 3:158-167. 2019
- Evidence to Decision framework provides a structured “roadmap” for making GRADE guidelines recommendations. Journal of Clinical Epidemiology. 104:103-112. 2018
- Outcome Measures in Rheumatology - Interventions for medication Adherence (OMERACT-Adherence) Core Domain Set for Trials of Interventions for Medication Adherence in Rheumatology: 5 Phase Study Protocol. Trials. 19:204. 2018
- American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy. Blood Advances. 2:3257-3291. 2018
- American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients. Blood Advances. 2:3198-3225. 2018
- Increased burden of comorbidities and risk of cardiovascular death in atrial fibrillation patients in Europe over ten years: A comparison between EORP-AF pilot and EHS-AF registries. European Journal of Internal Medicine. 55:28-34. 2018
- Effect of Systemic Hypertension With Versus Without Left Ventricular Hypertrophy on the Progression of Atrial Fibrillation (from the Euro Heart Survey). American Journal of Cardiology. 122:578-583. 2018
- Improving medication adherence in patients with cardiovascular disease: a systematic review. Heart. 104:1238-1243. 2018
- P4799When are atrial fibrillation patients at risk to discontinue anticoagulation treatment? Results from the GLORIA-AF Registry. European Heart Journal. 39:ehy563.p4799. 2018
- Development, Testing, and Implementation of a Training Curriculum for Nonphysician Health Workers to Reduce Cardiovascular Disease. Global Heart. 13:93-93. 2018
- The influence of progression of atrial fibrillation on quality of life: a report from the Euro Heart Survey. Europace. 20:929-934. 2018
- Developing consensus measures for global programs: lessons from the Global Alliance for Chronic Diseases Hypertension research program. Globalization and Health. 13:17. 2017
- Erratum to: Effectiveness and content analysis of interventions to enhance medication adherence in hypertension: a systematic review and meta-analysis protocol. Systematic Reviews. 6:30. 2017
- Symptomatic atrial fibrillation and risk of cardiovascular events: data from the Euro Heart Survey. Europace. 19:1922-1929. 2017
- Congruence between patient characteristics and interventions may partly explain medication adherence intervention effectiveness: an analysis of 190 randomized controlled trials from a Cochrane systematic review. Journal of Clinical Epidemiology. 91:70-79. 2017
- Effectiveness and content analysis of interventions to enhance medication adherence and blood pressure control in hypertension: A systematic review and meta-analysis. Psychology and Health. 32:1195-1232. 2017
- Persistence With Dabigatran Therapy at 2 Years in Patients With Atrial Fibrillation. Journal of the American College of Cardiology. 70:1573-1583. 2017
- The role of pragmatism in explaining heterogeneity in meta-analyses of randomised trials: a protocol for a cross-sectional methodological review. BMJ Open. 7:e017887-e017887. 2017
- 5769Changes in thromboembolic risk profile and antithrombotic therapy use over a decade: a comparison of Euro Heart Survey on AF and EURObservational research programme AF pilot registry. European Heart Journal. 38:ehx493.5769. 2017
- P1380Gender differences in the progression of atrial fibrillation in low-risk paroxysmal AF patients with hypertension: the role of left ventricular hypertrophy. Europace. 19:iii269-iii270. 2017
- P283The influence of progression of atrial fibrillation on quality of life: a report from the euro heart survey. Europace. 19:iii40-iii40. 2017
- MP09: Canadian Community Utilization of Stroke Prevention Pilot Study-Emergency Department (C-CUSP ED). Canadian Journal of Emergency Medicine. 19:S68-S68. 2017
- Living systematic review: 1. Introduction—the why, what, when, and how. Journal of Clinical Epidemiology. 91:23-30. 2017
- Living systematic reviews: 2. Combining human and machine effort. Journal of Clinical Epidemiology. 91:31-37. 2017
- Living systematic reviews: 3. Statistical methods for updating meta-analyses. Journal of Clinical Epidemiology. 91:38-46. 2017
- Living systematic reviews: 4. Living guideline recommendations. Journal of Clinical Epidemiology. 91:47-53. 2017
- Effectiveness and content analysis of interventions to enhance medication adherence in hypertension: a systematic review and meta-analysis protocol. Systematic Reviews. 5:96. 2016
- Identifying Patients With Atrial Fibrillation in Administrative Data. Canadian Journal of Cardiology. 32:1561-1565. 2016
- The Global Alliance for Chronic Diseases Supports 15 Major Studies in Hypertension Prevention and Control in Low‐ and Middle‐Income Countries. Journal of the cardiometabolic syndrome. 18:600-605. 2016
- Mobile Text Messaging and Adherence of Patients to Medication Prescriptions. JAMA Internal Medicine. 176:350-350. 2016
- Matching Adherence Interventions to Patient Determinants Using the Theoretical Domains Framework. Frontiers in Pharmacology. 7:429. 2016
- Behaviour change strategies for reducing blood pressure-related disease burden: findings from a global implementation research programme. Implementation Science. 10:158. 2015
- Understanding the modifiable health systems barriers to hypertension management in Malaysia: a multi-method health systems appraisal approach. BMC Health Services Research. 15:254. 2015
- Technology-mediated interventions for enhancing medication adherence. Journal of the American Medical Informatics Association : JAMIA. 22:e177-e193. 2015
- Patients’ Knowledge, Attitudes, Behaviour and Health Care Experiences on the Prevention, Detection, Management and Control of Hypertension in Colombia: A Qualitative Study. PLoS ONE. 10:e0122112-e0122112. 2015
- Tricuspid Valve Regurgitation Following Temporary or Permanent Endocardial Lead Insertion, and the Impact of Cardiac Resynchronization Therapy. Open Cardiovascular Medicine Journal. 8:113-120. 2014
- Interventions for enhancing medication adherence. Cochrane Database of Systematic Reviews. 2014:CD000011. 2014
- Stroke and Bleeding Risk Co-distribution in Real-world Patients with Atrial Fibrillation: The Euro Heart Survey. American Journal of Medicine. 127:979-986.e2. 2014
- Gaps in Medical and Device Therapy for Patients with Left Ventricular Systolic Dysfunction: The EchoGap Study. Open Cardiovascular Medicine Journal. 8:94-101. 2014
- Cluster randomized controlled trial of a simple warfarin maintenance dosing algorithm versus usual care among primary care practices. Journal of Thrombosis and Thrombolysis. 37:435-442. 2014
- Combination pharmacotherapy to prevent cardiovascular disease: present status and challenges. European Heart Journal. 35:353-364. 2014
- Patient and Healthcare Provider Barriers to Hypertension Awareness, Treatment and Follow Up: A Systematic Review and Meta-Analysis of Qualitative and Quantitative Studies. PLoS ONE. 9:e84238-e84238. 2014
- Management of dyspepsia symptoms on dabigatran during RELY-ABLE: long-term follow up study after RE-LY. European Heart Journal. 34:p549. 2013
- Abstract 182: The Impact of National and Regional Health Systems Arrangements on Hypertension Awareness, Treatment and Control: a Systematic Literature Review. Circulation. Cardiovascular Quality and Outcomes. 6. 2013
- Abstract 329: Barriers To Hypertension Screening, Treatment And Control As Reported By Patients And Healthcare Providers. Circulation. Cardiovascular Quality and Outcomes. 6. 2013
- Why are we failing to implement effective therapies in cardiovascular disease?. European Heart Journal. 34:1262-1269. 2013
- Features of effective computerised clinical decision support systems: meta-regression of 162 randomised trials. The BMJ. 346:f657-f657. 2013
- Potential net clinical benefit of population-wide implementation of apixaban and dabigatran among European patients with atrial fibrillation. Thrombosis and Haemostasis. 109:328-336. 2013
- The Influence of Health Systems on Hypertension Awareness, Treatment, and Control: A Systematic Literature Review. PLoS Medicine. 10:e1001490-e1001490. 2013
- Patients originally diagnosed with idiopathic atrial fibrillation more often suffer from insidious coronary artery disease compared to healthy sinus rhythm controls. Heart Rhythm. 9:1923-1929. 2012
- Variation in Warfarin Dose Adjustment Practice Is Responsible for Differences in the Quality of Anticoagulation Control Between Centers and Countries. Circulation. 126:2309-2316. 2012
- Characteristics, management and prognosis of elderly patients in the Euro Heart Survey on atrial fibrillation. Aging - Clinical and Experimental Research. 24:517-523. 2012
- Characteristics, management and prognosis of elderly patients in the Euro Heart Survey on atrial fibrillation.. Aging - Clinical and Experimental Research. 24:517-523. 2012
- Quality of individual INR control and the risk of stroke and bleeding events in atrial fibrillation patients: A nested case control analysis of the ACTIVE W study. Thrombosis Research. 129:715-719. 2012
- Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart Survey. Europace. 14:666-674. 2012
- Idiopathic atrial fibrillation revisited in a large longitudinal clinical cohort. Europace. 14:184-190. 2012
- Randomised comparison of a simple warfarin dosing algorithm versus a computerised anticoagulation management system for control of warfarin maintenance therapy. Thrombosis and Haemostasis. 108:1228-1235. 2012
- Dronedarone in High-Risk Permanent Atrial Fibrillation. New England Journal of Medicine. 365:2268-2276. 2011
- Computerized clinical decision support systems for therapeutic drug monitoring and dosing: A decision-maker-researcher partnership systematic review. Implementation Science. 6:90. 2011
- Abstract P131: Importance of Algorithm-Consistent Warfarin Dosing in the Quality of Anticoagulation Control in Atrial Fibrillation: A Multilevel Analysis. Circulation. Cardiovascular Quality and Outcomes. 4. 2011
- Abstract P192: The Gap Between Guidelines and Practice for the Total Cardiovascular Care of Atrial Fibrillation Patients in an Extended Study for Re-ly Patients Receiving Dabigatran. Circulation. Cardiovascular Quality and Outcomes. 4. 2011
- Abstract P199: Randomized Comparison of the DAWN AC Computer Program and a Simple Manual Nomogram for Quality of Warfarin Dosing. Circulation. Cardiovascular Quality and Outcomes. 4. 2011
- Abstract P200: Computerized Clinical Decision Support Systems for Therapeutic Drug Monitoring and Dosing: A Decision Maker--Researcher Partnership Systematic Review. Circulation. Cardiovascular Quality and Outcomes. 4. 2011
- Abstract P6: Vitamin K Antagonist Dosing Methods and Individual Patient Quality of INR Control in the International Active W Anticoagulation Study. Circulation. Cardiovascular Quality and Outcomes. 4. 2011
- Abstract P7: The Impact of Cardiovascular Hospitalization on Mortality and Quality of Life Among 14,261 Atrial Fibrillation Patients in the ACTIVE Study. Circulation. Cardiovascular Quality and Outcomes. 4. 2011
- Patients using vitamin K antagonists show increased levels of coronary calcification: an observational study in low-risk atrial fibrillation patients. European Heart Journal. 32:2555-2562. 2011
- The burden of atrial fibrillation in the Netherlands. Netherlands Heart Journal. 19:373-378. 2011
- Assessing the Performance of the HAS-BLED Score: Response. Chest. 139:1248-1248. 2011
- The HAS-BLED Score and Renal Failure: Response. Chest. 139:1249-1250. 2011
- The value of cardiovascular hospitalization as an endpoint for clinical atrial fibrillation research. Europace. 13:601-602. 2011
- Predictors of costs related to cardiovascular disease among patients with atrial fibrillation in five European countries. Europace. 13:23-30. 2011
- Statins Do Not Reduce Atrial Fibrillation After Cardiac Valvular Surgery: A Single Centre Observational Study. Netherlands Heart Journal. 19:17-23. 2011
- Systematic Review to Identify Validated Manual Warfarin Maintenance Dosing Tools.. Blood. 116:3800. 2010
- A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation. Chest. 138:1093-1100. 2010
- CHA 2 DS 2 -VASc Risk Scheme: Response. Chest. 138:1020-1021. 2010
- Improving guideline adherence in the treatment of atrial fibrillation by implementing an integrated chronic care program. Netherlands Heart Journal. 18:471-477. 2010
- Lenient rate control is as effective as strict rate control for preventing cardiovascular events in AF. ACP journal club. 153:JC2-JC2. 2010
- Obstructive Sleep Apnea Is a Risk Factor for Stroke and Atrial Fibrillation: Response. Chest. 138:239-240. 2010
- Factors determining utility measured with the EQ-5D in patients with atrial fibrillation. Quality of Life Research. 19:381-390. 2010
- Underuse of evidence-based warfarin dosing methods for atrial fibrillation patients. Thrombosis Research. 125:e128-e131. 2010
- Progression From Paroxysmal to Persistent Atrial Fibrillation. Journal of the American College of Cardiology. 55:725-731. 2010
- Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach. Chest. 137:263-272. 2010
- Effect of a simple two‐step warfarin dosing algorithm on anticoagulant control as measured by time in therapeutic range: a pilot study. Journal of Thrombosis and Haemostasis. 8:101-106. 2010
- Reply. Journal of the American College of Cardiology. 55:168-169. 2010
- Abstract 5795: Impact of the Modified Henry Ford Warfarin Maintenance Dosing Algorithm on Quality of Anticoagulation at a Specialist Anticoagulation Clinic. Circulation. 120. 2009
- Use and Underuse of Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation: Old and New Paradigms. Seminars in Vascular Medicine. 35:554-559. 2009
- Atrial Fibrillation and Heart Failure in Cardiology Practice: Reciprocal Impact and Combined Management From the Perspective of Atrial Fibrillation. Journal of the American College of Cardiology. 53:1690-1698. 2009
- Atrial tissue Doppler imaging for prediction of new-onset atrial fibrillation. Heart. 95:835-840. 2009
- Comprehensive upstream treatment for atrial fibrillation, when and how?. Europace. 11:397-399. 2009
- Stroke prevention in atrial fibrillation: better use of anticoagulation and new agents will lead to improved outcomes. Heart. 95:95-97. 2009
- Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on Atrial Fibrillation. European Heart Journal. 29:1181-1189. 2008
- Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillation. Europace. 10:403-411. 2008
- Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation?. European Heart Journal. 29:915-922. 2008
- Autonomic trigger patterns and anti-arrhythmic treatment of paroxysmal atrial fibrillation: data from the Euro Heart Survey. European Heart Journal. 29:632-639. 2008
- Atrial fibrillation in the ‘real world’: undecided issues. European Heart Journal, Supplement. 9:I122-I128. 2007
- Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation. American Heart Journal. 153:1006-1012. 2007
- The Euro Heart Survey Program: What's in It for Nurses?. Progress in Cardiovascular Nursing. 22:166-168. 2007
- Gender-Related Differences in Presentation, Treatment, and Outcome of Patients With Atrial Fibrillation in Europe. Journal of the American College of Cardiology. 49:572-577. 2007
- Antithrombotic drug prescription in atrial fibrillation and its rationale among general practitioners, internists and cardiologists in The Netherlands - The EXAMINE-AF study. A questionnaire survey. International Journal of Clinical Practice. 61:24-31. 2007
- Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation. European Heart Journal. 27:3018-3026. 2006
- EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. European Heart Journal. 27:2725-2736. 2006
- Sustained benefit 20 years after reperfusion therapy in acute myocardial infarction. Journal of Emergency Medicine. 30:250. 2006
- Which Factors Are Associated with the Application of Reperfusion Therapy in ST-Elevation Acute Coronary Syndromes?. Cardiology. 106:137-146. 2006
- Atrial fibrillation management: a prospective survey in ESC Member Countries. European Heart Journal. 26:2422-2434. 2005
- Sustained Benefit 20 Years After Reperfusion Therapy in Acute Myocardial Infarction. ACC Current Journal Review. 14:2. 2005
- Sustained Benefit 20 Years After Reperfusion Therapy in Acute Myocardial Infarction. Journal of the American College of Cardiology. 46:15-20. 2005
- The prevalence of abnormal glucose regulation in patients with coronary artery disease across EuropeThe Euro Heart Survey on diabetes and the heart. European Heart Journal. 25:1880-1890. 2004
- [Treatment of patients with acute coronary syndromes in the Netherlands in 2000-2001; a comparison with other European countries and with the guidelines].. Nederlands Tijdschrift voor Geneeskunde. 148:1878-1882. 2004
- 1313: Management of ST-Elevation Acute Coronary Syndrome Patients. A Nurses' View on the Euro Heart Survey on Acute Coronary Syndromes. European Journal of Cardiovascular Nursing. 3:83-84. 2004
- 1369: Quality of Life in Patients With Established Coronary Heart Disease: Results from the Euro Heart Survey on Coronary Revascularization (EHS-CR). European Journal of Cardiovascular Nursing. 3:112-113. 2004
- Continuously improving the practice of cardiology.. Netherlands Heart Journal. 12:110-116. 2004
- Increased uncoupling protein 3 content does not affect mitochondrial function in human skeletal muscle in vivo. Journal of Clinical Investigation. 111:479-486. 2003
- Increased uncoupling protein 3 content does not affect mitochondrial function in human skeletal muscle in vivo. Journal of Clinical Investigation. 111:479-486. 2003